Literature DB >> 8491690

Objective evaluation of 3-D radiation treatment plans: a decision-analytic tool incorporating treatment preferences of radiation oncologists.

N L Jain1, M G Kahn, R E Drzymala, B E Emami, J A Purdy.   

Abstract

PURPOSE: Selecting the optimal radiation treatment plan from a set of competing plans involves making trade-offs among the doses delivered to the target volumes and normal tissues by the competing plans. Evaluation of 3-dimensional radiation treatment plans is difficult because it requires the review of vast amount of graphical and numerical data. We have developed an objective plan-ranking model based on the concepts of decision analysis. METHODS AND MATERIALS: Our model ranks a set of tentative radiation treatment plans from best to worst. A figure of merit is computed for each plan based on probabilities of possible clinical complications such as non-eradication of the tumor and radiation induced damage to the nearby healthy normal tissues, and weights which indicate their clinical relevance. This figure of merit is used to rank the plans. Key issues addressed by the model include the incorporation of individual treatment preferences of the radiation oncologist and clinical features of the patient.
RESULTS: A methodology has been established for eliciting the treatment preferences of radiation oncologists. Results of this elicitation, and examples of several plan evaluations are presented. An interactive computer-based tool has been developed as one of a set of tools to assist in the evaluation of 3-dimensional radiation treatment plans.
CONCLUSION: The paper presents a decision-analytic model incorporating radiation oncologists' treatment preferences and an interactive computer-based tool for objectively ranking competing radiation treatment plans. The tool can be used by radiation oncologists for the evaluation of competing plans, or as part of a system which tries to automatically generate optimal treatment plans using mathematical or symbolic techniques.

Entities:  

Mesh:

Year:  1993        PMID: 8491690     DOI: 10.1016/0360-3016(93)90213-f

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  SPIDERplan: A tool to support decision-making in radiation therapy treatment plan assessment.

Authors:  Tiago Ventura; Maria do Carmo Lopes; Brigida Costa Ferreira; Leila Khouri
Journal:  Rep Pract Oncol Radiother       Date:  2016-08-24

2.  Objective evaluation of radiation treatment plans.

Authors:  N L Jain; M G Kahn
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1993

3.  Modeling physician's preference in treatment plan approval of stereotactic body radiation therapy of prostate cancer.

Authors:  Yin Gao; Chenyang Shen; Yesenia Gonzalez; Xun Jia
Journal:  Phys Med Biol       Date:  2022-05-26       Impact factor: 4.174

4.  Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Federica Cattani; Cristina Garibaldi; Dario Zerini; Cristiana Fodor; Flavia Serafini; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

5.  A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov model.

Authors:  Wade P Smith; Jason Doctor; Jürgen Meyer; Ira J Kalet; Mark H Phillips
Journal:  Artif Intell Med       Date:  2009-01-20       Impact factor: 5.326

6.  A dose-volume-based tool for evaluating and ranking IMRT treatment plans.

Authors:  Moyed M Miften; Shiva K Das; Min Su; Lawrence B Marks
Journal:  J Appl Clin Med Phys       Date:  2004-10-01       Impact factor: 2.102

7.  Clinical validation of a graphical method for radiation therapy plan quality assessment.

Authors:  Tiago Ventura; Joana Dias; Leila Khouri; Eduardo Netto; André Soares; Brigida da Costa Ferreira; Humberto Rocha; Maria do Carmo Lopes
Journal:  Radiat Oncol       Date:  2020-03-12       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.